The results of two large randomised controlled trials conducted in Africa that tested mefloquine, a drug for malaria prevention in HIV-negative and HIV-positive pregnant women, were published in the PLOS Medicine on 23 September 2014. The results sho...Read more » News, Announcements'
The European & Developing Countries Clinical Trials Partnership (EDCTP) published its report of the Stakeholder meeting on capacity development. The meeting was held in Berlin, Germany, on 3 July 2014 and hosted by the German Federal Ministry of Scie...Read more » News, Announcements'
Today, the European & Developing Countries Clinical Trials Partnership (EDCTP), RAND Europe and Baird’s CMC have published a report on the current state of health research and national funding commitments for HIV/AIDS, tuberculosis, malaria and negle...Read more » News, Announcements'
A high-level event in Cape Town, South Africa, on 2 December 2014 will celebrate the launch of the second programme of the European & Developing Countries Clinical Trials Partnership (EDCTP2).Read more » News, Announcements'
The results of REMoxTB, a phase III global clinical trial of new tuberculosis drug regimens, were published in the New England Journal of Medicine. The trial was led by Prof. Stephen H. Gillespie (St. Andrews University, Scotland) and conducted mainl...Read more » Announcements, News'
The diagnosis of paediatric tuberculosis is marred with difficulty, mainly due to the challenge in collecting sputum samples. A European & Developing Countries Clinical Trials-funded project (TB CHILD) has developed a new immunodiagnostic tool TAM-...Read more » News, Announcements'
The combination of a boosted protease inhibitor (lopinavir) with two nucleoside reverse-transcriptase inhibitors (NRTIs) is a feasible second-line therapy for HIV patients in Africa. These are the results of the EDCTP-funded EARNEST trial, coordinate...Read more »